Turning biological complexity
into clinical clarity

Spatial biology for personalized medicine

MultivisionDx builds AI-powered decision-support tools for personalized diagnosis and treatment selection for solid cancers. Our computer vision technology integrates unique biological and spatial features of the tumor and its microenvironment, flagging patients at risk of therapy failure in standard-of-care treatments. This approach provides clinicians with actionable insights for tailoring the most effective treatment strategies for individual patients.

Built on award-winning research at the University of Helsinki and published in Cell, the technology establishes a new standard in tumor profiling.

Milestones

Dec/25

1M Pre-seed funding round

MultivisionDx announces its first VC funding to accelerate development

Oct/25

Medix Prize

MultivisionDx proof-of-concept named top biomedical study in Finland

April/25

Company launched

MultivisionDx launches as a spinout from the University of Helsinki following a successful Research-to-Business project

Oct/24

Publication in Cell

Proof-of-concept in 650 head-and-neck cancer patients published in top scientific journal
Jan/23

Launch of MultivisionDx project

Supported by University of Helsinki and Business Finland

Nov/22

Secured €680k Business Finland funding

Research to Business funding granted for two year commercialization project

Latest news

Show all